South Dakota Investment Council Enanta Pharmaceuticals Inc Transaction History

South Dakota Investment Council

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$60.19 - $97.37 $92,451 - $149,560	-1,536 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$41.02 - $58.65 $1.07 Million - $1.52 Million	-26,000 Reduced 94.42%	1,536 $87,000
Q2 2021 Aug 11, 2021	BUY	$43.76 - $53.11 $472,170 - $573,056	10,790 Added 64.43%	27,536 $1.21 Million
Q1 2021 May 13, 2021	BUY	$41.69 - $54.95 $410,479 - $541,037	9,846 Added 142.7%	16,746 $826,000
Q4 2019 Feb 11, 2020	SELL	$57.95 - $66.61 $110,105 - $126,559	-1,900 Reduced 21.59%	6,900 $426,000
Q3 2019 Nov 13, 2019	BUY	$60.08 - $88.17 $480,640 - $705,360	8,000 Added 1000.0%	8,800 $529,000
Q1 2019 May 03, 2019	BUY	$69.08 - $105.66 $55,264 - $84,528	800 New	800 $76,000

108

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.